RIVFLOZA 80 mg/.5mL (Nedosiran INJECTION, SOLUTION) 80 mg/.5mL

RIVFLOZA 80 mg/0.5mL is a subcutaneous injection solution containing nedosiran. This medication is used to manage certain metabolic conditions. Learn more about its uses and effects.

Strength

80 mg/.5mL

Pack Size

1 VIAL in 1 CARTON (0169-5308-01) / .5 mL in 1 VIAL

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RIVFLOZA 80 mg/0.5mL is primarily used for the treatment of specific metabolic disorders. It works by targeting underlying mechanisms to help manage symptoms. People often ask, 'What is nedosiran used for?' This medication is designed to support metabolic health and improve quality of life for those with related conditions.

Side Effects

Common effects of RIVFLOZA 80 mg/0.5mL may include localized reactions at the injection site, such as redness or swelling. Some users might experience general discomfort or mild systemic reactions. These effects are typically temporary and subside as the body adjusts to the medication.

Precautions & Warnings

RIVFLOZA 80 mg/0.5mL should be handled with care, ensuring proper storage and administration techniques. It is important to follow healthcare provider instructions for safe use. Always check for any signs of contamination or damage to the vial before use.

Avoid Interactions

RIVFLOZA 80 mg/0.5mL may interact with certain medications, including those metabolized by specific liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect how this medication works.

Frequently Asked Questions

RIVFLOZA 80 mg/0.5mL is used to manage certain metabolic conditions by targeting underlying mechanisms.

RIVFLOZA 80 mg/0.5mL is administered subcutaneously, typically by a healthcare professional or as directed.

Common side effects may include localized reactions at the injection site, such as redness or swelling.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

RIVFLOZA 80 mg/0.5mL should be stored as per the manufacturer's instructions to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.